The control of melanoma in New Zealand
- PMID: 16998570
The control of melanoma in New Zealand
Abstract
Aims: This study estimated the impact of prevention, screening, early diagnosis, and treatment on the burden of melanoma in New Zealand.
Methods: Cancer control plans and management guidelines were reviewed to identify activities that could reduce the burden of melanoma in New Zealand and an estimation was made of their effects on incidence and mortality. The base year for estimating changes in incidence and mortality was the published melanoma data for 2002.
Results: The registration of melanoma increased from 1037 new registrations in 1993 to 1487 in 1994 and peaked at 1759 in 1995. In 2002 a further increase occurred, to 1842 new registrations and 235 deaths from melanoma. It is likely that 328 of the 1842 new cases of melanoma in 2002 were directly attributable to severe sunburn. A reduction of 10% in the number of people getting severely sunburnt could prevent 28 melanoma cases per year. If 2% of melanoma deaths occur in high-risk individuals, approximately 4 deaths per year could be prevented by surveillance of high-risk groups. Thin melanoma has a very good prognosis: a 10% shift in the depth distribution into the thinnest depth category would result in about 29 deaths from melanoma prevented each year.
Conclusions: The best avenues for reducing the burden of melanoma in New Zealand are prevention of excessive sun exposure and early diagnosis. Reducing severe sunburn and diagnosing a greater proportion of melanomas when they are thin would have the greatest impact on the incidence of and mortality from melanoma.
Comment in
-
Melanoma control: few answers, many questions.N Z Med J. 2006 Sep 22;119(1242):U2172. N Z Med J. 2006. PMID: 16998573 No abstract available.
Similar articles
-
Melanoma control: few answers, many questions.N Z Med J. 2006 Sep 22;119(1242):U2172. N Z Med J. 2006. PMID: 16998573 No abstract available.
-
Prospects for cancer control: colorectal cancer.N Z Med J. 2005 Aug 26;118(1221):U1632. N Z Med J. 2005. PMID: 16138170
-
Cutaneous melanoma: public health approach to early detection.Dermatol Ther. 2006 Jan-Feb;19(1):26-31. doi: 10.1111/j.1529-8019.2005.00053.x. Dermatol Ther. 2006. PMID: 16405567 Review.
-
Targeting early detection of malignant melanoma of the skin.N Z Med J. 1990 Nov 28;103(902):551-3. N Z Med J. 1990. PMID: 2243650
-
[Prevention of cutaneous melanoma].Ned Tijdschr Geneeskd. 1999 Jun 26;143(26):1356-9. Ned Tijdschr Geneeskd. 1999. PMID: 10416492 Review. Dutch.
Cited by
-
Connectedness to nature and public (skin) health perspectives: results of a representative, population-based survey among Austrian residents.Int J Environ Res Public Health. 2014 Jan 20;11(1):1176-91. doi: 10.3390/ijerph110101176. Int J Environ Res Public Health. 2014. PMID: 24448634 Free PMC article.
-
Cutaneous Melanoma in Asians.Chonnam Med J. 2016 Sep;52(3):185-93. doi: 10.4068/cmj.2016.52.3.185. Epub 2016 Sep 23. Chonnam Med J. 2016. PMID: 27689028 Free PMC article. Review.
-
Yes-Associated Protein (YAP) Promotes Tumorigenesis in Melanoma Cells Through Stimulation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1).Sci Rep. 2017 Nov 14;7(1):15528. doi: 10.1038/s41598-017-14764-4. Sci Rep. 2017. PMID: 29138479 Free PMC article.
-
Conflicts and contradictions in current skin cancer screening guidelines.Curr Dermatol Rep. 2017 Dec;6(4):316-324. doi: 10.1007/s13671-017-0205-6. Epub 2017 Nov 4. Curr Dermatol Rep. 2017. PMID: 33717657 Free PMC article.
-
Epidemiology of cutaneous melanoma in Blumenau, Santa Catarina state, Brazil from 1980 to 2019.An Bras Dermatol. 2023 Sep-Oct;98(5):611-619. doi: 10.1016/j.abd.2022.06.006. Epub 2023 Apr 28. An Bras Dermatol. 2023. PMID: 37121789 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical